
Formats: [HTML](/news/2015/04/21/israeli-generics-giant-teva-pharmaceutical-offers-4-billion-to-acquire-us-rival-mylan.html)  [JSON](/news/2015/04/21/israeli-generics-giant-teva-pharmaceutical-offers-4-billion-to-acquire-us-rival-mylan.json)  [XML](/news/2015/04/21/israeli-generics-giant-teva-pharmaceutical-offers-4-billion-to-acquire-us-rival-mylan.xml)  

### [2015-04-21](/news/2015/04/21/index.md)

##### Teva Pharmaceutical
# Israeli generics giant Teva Pharmaceutical offers $4 billion to acquire US rival Mylan. 




### Sources:

1. [Economic Times](http://economictimes.indiatimes.com/markets/stocks/news/tevas-hostile-bid-for-mylan-deal-could-open-up-a-2-billion-opportunity-for-pharma-companies/articleshow/47020872.cms)

### Related:

1. [Israeli company Teva Pharmaceutical, the world's largest generic drug manufacturer, is restructuring in order to pay off debt, and will be cutting its work force by about a quarter. ](/news/2017/12/14/israeli-company-teva-pharmaceutical-the-world-s-largest-generic-drug-manufacturer-is-restructuring-in-order-to-pay-off-debt-and-will-be-c.md) _Context: Teva Pharmaceutical_
2. [Mylan pays US$465 million to settle its underpayment to U.S. government healthcare programs by misclassifying its epinephrine autoinjector emergency allergy treatment. ](/news/2016/10/7/mylan-pays-us-465-million-to-settle-its-underpayment-to-u-s-government-healthcare-programs-by-misclassifying-its-epinephrine-autoinjector-e.md) _Context: Mylan_
3. [Mylan, a manufacturer of generic drugs, announced that its board has no interest in much-discussed prospect of purchase by Teva Pharmaceuticals, one of the 15 largest pharmaceutical concerns in the world. ](/news/2015/04/17/mylan-a-manufacturer-of-generic-drugs-announced-that-its-board-has-no-interest-in-much-discussed-prospect-of-purchase-by-teva-pharmaceutic.md) _Context: Mylan_
